BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 20508211)

  • 1. Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipients.
    Finlen Copeland CA; Snyder LD; Zaas DW; Turbyfill WJ; Davis WA; Palmer SM
    Am J Respir Crit Care Med; 2010 Sep; 182(6):784-9. PubMed ID: 20508211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is transplant operation important in determining posttransplant risk of bronchiolitis obliterans syndrome in lung transplant recipients?
    Hadjiliadis D; Davis RD; Palmer SM
    Chest; 2002 Oct; 122(4):1168-75. PubMed ID: 12377838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.
    Heng D; Sharples LD; McNeil K; Stewart S; Wreghitt T; Wallwork J
    J Heart Lung Transplant; 1998 Dec; 17(12):1255-63. PubMed ID: 9883768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor factors are associated with bronchiolitis obliterans syndrome after lung transplantation.
    Hennessy SA; Hranjec T; Swenson BR; Kozower BD; Jones DR; Ailawadi G; Kron IL; Lau CL
    Ann Thorac Surg; 2010 May; 89(5):1555-62. PubMed ID: 20417777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Course of FEV(1) after onset of bronchiolitis obliterans syndrome in lung transplant recipients.
    Lama VN; Murray S; Lonigro RJ; Toews GB; Chang A; Lau C; Flint A; Chan KM; Martinez FJ
    Am J Respir Crit Care Med; 2007 Jun; 175(11):1192-8. PubMed ID: 17347496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?
    Burton CM; Iversen M; Mortensen J; Carlsen J; Andersen CB; Milman N; Scheike T
    J Heart Lung Transplant; 2007 Nov; 26(11):1127-34. PubMed ID: 18022078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group.
    Sundaresan S; Trulock EP; Mohanakumar T; Cooper JD; Patterson GA
    Ann Thorac Surg; 1995 Nov; 60(5):1341-6; discussion 1346-7. PubMed ID: 8526624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate postoperative inflammatory response predicts long-term outcome in lung-transplant recipients.
    Hall DJ; Baz M; Daniels MJ; Staples ED; Klodell CT; Moldawer LL; Beaver TM
    Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):603-7. PubMed ID: 22815323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term survival after lung transplantation depends on development and severity of bronchiolitis obliterans syndrome.
    Burton CM; Carlsen J; Mortensen J; Andersen CB; Milman N; Iversen M
    J Heart Lung Transplant; 2007 Jul; 26(7):681-6. PubMed ID: 17613397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation.
    Glanville AR; Aboyoun CL; Havryk A; Plit M; Rainer S; Malouf MA
    Am J Respir Crit Care Med; 2008 May; 177(9):1033-40. PubMed ID: 18263803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchiolitis obliterans syndrome-free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis.
    Kulkarni HS; Cherikh WS; Chambers DC; Garcia VC; Hachem RR; Kreisel D; Puri V; Kozower BD; Byers DE; Witt CA; Alexander-Brett J; Aguilar PR; Tague LK; Furuya Y; Patterson GA; Trulock EP; Yusen RD
    J Heart Lung Transplant; 2019 Jan; 38(1):5-16. PubMed ID: 30391193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome.
    Daud SA; Yusen RD; Meyers BF; Chakinala MM; Walter MJ; Aloush AA; Patterson GA; Trulock EP; Hachem RR
    Am J Respir Crit Care Med; 2007 Mar; 175(5):507-13. PubMed ID: 17158279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome.
    Jain R; Hachem RR; Morrell MR; Trulock EP; Chakinala MM; Yusen RD; Huang HJ; Mohanakumar T; Patterson GA; Walter MJ
    J Heart Lung Transplant; 2010 May; 29(5):531-7. PubMed ID: 20133163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-dependent changes in the risk of death in pure bronchiolitis obliterans syndrome (BOS).
    Sato M; Ohmori-Matsuda K; Saito T; Matsuda Y; Hwang DM; Waddell TK; Singer LG; Keshavjee S
    J Heart Lung Transplant; 2013 May; 32(5):484-91. PubMed ID: 23433813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome.
    Palmer SM; Davis RD; Hadjiliadis D; Hertz MI; Howell DN; Ward FE; Savik K; Reinsmoen NL
    Transplantation; 2002 Sep; 74(6):799-804. PubMed ID: 12364858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchiolitis obliterans syndrome after single-lung transplantation: impact of time to onset on functional pattern and survival.
    Brugière O; Pessione F; Thabut G; Mal H; Jebrak G; Lesèche G; Fournier M
    Chest; 2002 Jun; 121(6):1883-9. PubMed ID: 12065353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome.
    Valentine VG; Gupta MR; Walker JE; Seoane L; Bonvillain RW; Lombard GA; Weill D; Dhillon GS
    J Heart Lung Transplant; 2009 Feb; 28(2):163-9. PubMed ID: 19201342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-immune acute graft injury after lung transplantation and the risk of subsequent bronchiolitis obliterans syndrome (BOS).
    Fisher AJ; Wardle J; Dark JH; Corris PA
    J Heart Lung Transplant; 2002 Nov; 21(11):1206-12. PubMed ID: 12431494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchiolitis obliterans syndrome development in lung transplantation patients.
    Parada MT; Alba A; Sepúlveda C
    Transplant Proc; 2010; 42(1):331-2. PubMed ID: 20172344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Alemtuzumab and Basiliximab Induction on Patient Survival and Time to Bronchiolitis Obliterans Syndrome in Double Lung Transplantation Recipients.
    Furuya Y; Jayarajan SN; Taghavi S; Cordova FC; Patel N; Shiose A; Leotta E; Criner GJ; Guy TS; Wheatley GH; Kaiser LR; Toyoda Y
    Am J Transplant; 2016 Aug; 16(8):2334-41. PubMed ID: 26833657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.